These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 16645645)

  • 1. Chronic aspirin therapy for the prevention of cardiovascular events: a waste of time, or worse?
    Cleland JG
    Nat Clin Pract Cardiovasc Med; 2006 May; 3(5):234-5. PubMed ID: 16645645
    [No Abstract]   [Full Text] [Related]  

  • 2. Can the time of taking aspirin influence the frequency of cardiovascular events?
    Kriszbacher I; Ajtay Z; Koppán M; Bódis J
    Am J Cardiol; 2005 Aug; 96(4):608-10. PubMed ID: 16098324
    [No Abstract]   [Full Text] [Related]  

  • 3. [Aspirin in cardiovascular prevention: does the approach differ by gender?].
    Temizhan A
    Anadolu Kardiyol Derg; 2007 Dec; 7 Suppl 2():2-4. PubMed ID: 18160359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Use of aspirin in diabetic patients].
    Türkoğlu S; Abaci A
    Anadolu Kardiyol Derg; 2007 Dec; 7 Suppl 2():5-8. PubMed ID: 18160360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aspirin for the primary prevention of cardiovascular events: recommendations and rationale.
    U.S. Preventive Services Task Force
    Am J Nurs; 2002 Mar; 102(3):67, 69-70. PubMed ID: 11976531
    [No Abstract]   [Full Text] [Related]  

  • 6. Antiplatelet therapy.
    Wood SF
    Br J Gen Pract; 1996 Aug; 46(409):494-5. PubMed ID: 8949338
    [No Abstract]   [Full Text] [Related]  

  • 7. Lower aspirin doses in dual antiplatelet therapy optimise efficacy and safety: CHARISMA follow-up study.
    Cardiovasc J Afr; 2009; 20(3):205. PubMed ID: 19575092
    [No Abstract]   [Full Text] [Related]  

  • 8. Aspirin resistance: is it real? Is it clinically significant?
    Dalen JE
    Am J Med; 2007 Jan; 120(1):1-4. PubMed ID: 17208069
    [No Abstract]   [Full Text] [Related]  

  • 9. Statins and aspirin in chronic kidney disease: what does the UK-HARP-I trial tell us?
    Krane V; Wanner C
    Am J Kidney Dis; 2005 Mar; 45(3):607-9. PubMed ID: 15754285
    [No Abstract]   [Full Text] [Related]  

  • 10. New guidelines refine aspirin prescription. Task force offers recommendation for women and guidance on dosage.
    Harv Heart Lett; 2009 Jun; 19(10):4-5. PubMed ID: 19681207
    [No Abstract]   [Full Text] [Related]  

  • 11. [Prevention of cardiovascular events with antiplatelet drugs: aspirin (and others)?].
    Patrono C
    Minerva Cardioangiol; 1999 Nov; 47(11):389-90. PubMed ID: 10641409
    [No Abstract]   [Full Text] [Related]  

  • 12. Overcoming aspirin resistance: increased platelet inhibition with combination aspirin and clopidogrel and high dose aspirin therapy in aspirin resistant patients with peripheral vascular disease.
    Wong S; Morel-Kopp MC; Chen Q; Appleberg M; Ward CM; Lewis DR
    Thromb Haemost; 2006 Jun; 95(6):1042-3. PubMed ID: 16732389
    [No Abstract]   [Full Text] [Related]  

  • 13. Aspirin for the primary prevention of cardiovascular events: recommendations and rationale.
    U.S. Preventive Services Task Force
    Am Fam Physician; 2002 May; 65(10):2107-10. PubMed ID: 12046780
    [No Abstract]   [Full Text] [Related]  

  • 14. The need for wider and appropriate utilization of aspirin and statins in the treatment and prevention of cardiovascular disease.
    Hennekens CH; Schneider WR
    Expert Rev Cardiovasc Ther; 2008 Jan; 6(1):95-107. PubMed ID: 18095910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Appropriate aspirin use for primary prevention of cardiovascular disease.
    Miser WF
    Am Fam Physician; 2011 Jun; 83(12):1380-6. PubMed ID: 21671538
    [No Abstract]   [Full Text] [Related]  

  • 16. [Aspirin therapy for cardiovascular prevention in the diabetic patient: what have we learned from the evidence?].
    Legrand DA; Scheen AJ
    Rev Med Suisse; 2006 Aug; 2(76):1904-8. PubMed ID: 16972540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aspirin and gastrointestinal toxicity.
    Törüner M
    Anadolu Kardiyol Derg; 2007 Dec; 7 Suppl 2():27-30. PubMed ID: 18160364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Results of the Women's Health Study].
    Zh Nevrol Psikhiatr Im S S Korsakova; 2005; (Suppl 14):54-5. PubMed ID: 16184856
    [No Abstract]   [Full Text] [Related]  

  • 19. Laboratory-defined aspirin resistance and recurrent cardiovascular events.
    Fontana P; Reny JL
    Arch Intern Med; 2008 Mar; 168(5):549-50. PubMed ID: 18332305
    [No Abstract]   [Full Text] [Related]  

  • 20. Aspirin and the prevention of cardiovascular disease in chronic kidney disease: time to move forward?
    Wali RK
    J Am Coll Cardiol; 2010 Sep; 56(12):966-8. PubMed ID: 20828649
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.